Find a Doctor
Shafeeq Ladha, MD, received his medical degree from the University of Arizona College of Medicine in Tucson in 2000. He subsequently completed his neurology residency at Barrow Neurological Institute at Dignity Health St. Joseph’s Hospital and Medical Center in Phoenix, where he was a chief resident in his final year. His experience treating patients with neuromuscular disorders during these years prompted him to seek subspecialty training in neuromuscular medicine.
Dr. Ladha completed a fellowship in neuromuscular disorders and peripheral nerve diseases at Mayo Clinic in Rochester, Minnesota in 2005. During this time he also became proficient at analyzing and interpreting nerve biopsies. In 2006, he completed another fellowship at Mayo Clinic in Scottsdale, Arizona in clinical neurophysiology and electromyography, where he learned common and specialized neurophysiologic techniques such as single fiber EMG and repetitive nerve stimulation.
Dr. Ladha returned to Barrow in 2007 as the director of the Barrow MDA Clinic and eventually opened the AANEM-accredited Barrow EMG laboratory. He holds faculty positions at both the University of Arizona College of Medicine and Creighton University.
For more information or to request an appointment, please call (602) 406-6262.
- Aetna
- Arizona Foundation
- Beech Street
- Blue Cross Blue Shield
- Cigna
- First Health
- Great West
- Health Choice
- Healthnet
- Humana
- Indian Health Services
- Medicare
- Mercy Care (AHCCCS)
- Phoenix Health Plan
- Scan Healthcare
- Secure Horizon
- Tricare
- United Healthcare
- Fellowship, Mayo Clinic (Rochester), Neuromuscular Disorders and Peripheral Nerve Diseases, 2005-2006
- Fellowship, Mayo Clinic (Scottsdale), Clinical Neurophysiology and EMG, 2004-2005
- Residency, Barrow Neurological Institute, Neurology, 2001-2004
- Internship, 2000-2001
- MD, University of Arizona College of Medicine, 2000
- BS, University of Notre Dame, 1996
- Fellow Member, American Association of Neuromuscular and Electrodiagnostic Medicine
- American Clinical Neurophysiology Society
- ALS Research Group
- Northeast ALS Consortium
- Peripheral Nerve Society
Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patients
Date: 09/2021
Authors: Carol Milligan, Nazem Atassi, Suma Babu, Richard J. Barohn, James B. Caress, Merit E. Cudkowicz, Armineuza Evora, Gregory A. Hawkins, Marlena Wosiski-Kuhn, Eric A. Macklin, Jeremy M. Shefner, Zachary Simmons, Robert P. Bowser, Shafeeq S. Ladha
Evaluation of amyotrophic lateral sclerosis-induced muscle degeneration using magnetic resonance-based relaxivity contrast imaging (RCI)
Date: 06/2021
Authors: Sudarshan Ragunathan, Laura C. Bell, Natenael Semmineh, Ashley M. Stokes, Jeremy M. Shefner, Robert Bowser, Shafeeq Ladha, C. Chad Quarles
Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trial
Date: 03/2021
Authors: Michael D. Weiss, Eric A. Macklin, Courtney E. McIlduff, Steve Vucic, Brian J. Wainger, Matthew C. Kiernan, Stephen A. Goutman, Namita A. Goyal, Seward B. Rutkove, Shafeeq S. Ladha, I. Hweii Amy Chen, Matthew B. Harms, Thomas H. Brannagan, David Lacomis, Sasha Zivkovic, Maxwell Ma, Leo H. Wang, Zachary Simmons, Michael H. Rivner, Jeremy M. Shefner, Merit E. Cudkowicz, Nazem Atassi
Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial
Date: 02/2021
Authors: Brian J. Wainger, Eric A. Macklin, Steve Vucic, Courtney E. McIlduff, Sabrina Paganoni, Nicholas J. Maragakis, Richard Bedlack, Namita A. Goyal, Seward B. Rutkove, Dale J. Lange, Michael H. Rivner, Stephen A. Goutman, Shafeeq S. Ladha, Elizabeth A. Mauricio, Robert H. Baloh, Zachary Simmons, Lindsay Pothier, Sylvia Baedorf Kassis, Thuong La, Meghan Hall, Armineuza Evora, David Klements, Aura Hurtado, Joao D. Pereira, Joan Koh, Pablo A. Celnik, Vinay Chaudhry, Karissa Gable, Vern C. Juel, Nicolas Phielipp, Adel Marei
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis
Date: 01/2021
Authors: Sabrina Paganoni, Suzanne Hendrix, Samuel P. Dickson, Newman Knowlton, Eric A. Macklin, James D. Berry, Michael A. Elliott, Samuel Maiser, Chafic Karam, James B. Caress, Margaret Ayo Owegi, Adam Quick, James Wymer, Stephen A. Goutman, Daragh Heitzman, Terry D. Heiman-Patterson, Carlayne E. Jackson, Colin Quinn, Jeffrey D. Rothstein, Edward J. Kasarskis, Jonathan Katz, Liberty Jenkins, Shafeeq Ladha, Shafeeq S. Ladha, Timothy M. Miller, Stephen N. Scelsa, Tuan H. Vu, Christina N. Fournier, Jonathan D. Glass, Kristin M. Johnson, Andrea Swenson, Namita A. Goyal
- English
- (602) 406-6262
- Fax: (602) 406-6261
Shafeeq Ladha, MD, received his medical degree from the University of Arizona College of Medicine in Tucson in 2000. He subsequently completed his neurology residency at Barrow Neurological Institute at Dignity Health St. Joseph’s Hospital and Medical Center in Phoenix, where he was a chief resident in his final year. His experience treating patients with neuromuscular disorders during these years prompted him to seek subspecialty training in neuromuscular medicine.
Dr. Ladha completed a fellowship in neuromuscular disorders and peripheral nerve diseases at Mayo Clinic in Rochester, Minnesota in 2005. During this time he also became proficient at analyzing and interpreting nerve biopsies. In 2006, he completed another fellowship at Mayo Clinic in Scottsdale, Arizona in clinical neurophysiology and electromyography, where he learned common and specialized neurophysiologic techniques such as single fiber EMG and repetitive nerve stimulation.
Dr. Ladha returned to Barrow in 2007 as the director of the Barrow MDA Clinic and eventually opened the AANEM-accredited Barrow EMG laboratory. He holds faculty positions at both the University of Arizona College of Medicine and Creighton University.
For more information or to request an appointment, please call (602) 406-6262.
- (602) 406-6262
- Fax: (602) 406-6261
- Aetna
- Arizona Foundation
- Beech Street
- Blue Cross Blue Shield
- Cigna
- First Health
- Great West
- Health Choice
- Healthnet
- Humana
- Indian Health Services
- Medicare
- Mercy Care (AHCCCS)
- Phoenix Health Plan
- Scan Healthcare
- Secure Horizon
- Tricare
- United Healthcare
- Fellowship, Mayo Clinic (Rochester), Neuromuscular Disorders and Peripheral Nerve Diseases, 2005-2006
- Fellowship, Mayo Clinic (Scottsdale), Clinical Neurophysiology and EMG, 2004-2005
- Residency, Barrow Neurological Institute, Neurology, 2001-2004
- Internship, 2000-2001
- MD, University of Arizona College of Medicine, 2000
- BS, University of Notre Dame, 1996
- Fellow Member, American Association of Neuromuscular and Electrodiagnostic Medicine
- American Clinical Neurophysiology Society
- ALS Research Group
- Northeast ALS Consortium
- Peripheral Nerve Society
Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patients
Date: 09/2021
Authors: Carol Milligan, Nazem Atassi, Suma Babu, Richard J. Barohn, James B. Caress, Merit E. Cudkowicz, Armineuza Evora, Gregory A. Hawkins, Marlena Wosiski-Kuhn, Eric A. Macklin, Jeremy M. Shefner, Zachary Simmons, Robert P. Bowser, Shafeeq S. Ladha
Evaluation of amyotrophic lateral sclerosis-induced muscle degeneration using magnetic resonance-based relaxivity contrast imaging (RCI)
Date: 06/2021
Authors: Sudarshan Ragunathan, Laura C. Bell, Natenael Semmineh, Ashley M. Stokes, Jeremy M. Shefner, Robert Bowser, Shafeeq Ladha, C. Chad Quarles
Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trial
Date: 03/2021
Authors: Michael D. Weiss, Eric A. Macklin, Courtney E. McIlduff, Steve Vucic, Brian J. Wainger, Matthew C. Kiernan, Stephen A. Goutman, Namita A. Goyal, Seward B. Rutkove, Shafeeq S. Ladha, I. Hweii Amy Chen, Matthew B. Harms, Thomas H. Brannagan, David Lacomis, Sasha Zivkovic, Maxwell Ma, Leo H. Wang, Zachary Simmons, Michael H. Rivner, Jeremy M. Shefner, Merit E. Cudkowicz, Nazem Atassi
Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial
Date: 02/2021
Authors: Brian J. Wainger, Eric A. Macklin, Steve Vucic, Courtney E. McIlduff, Sabrina Paganoni, Nicholas J. Maragakis, Richard Bedlack, Namita A. Goyal, Seward B. Rutkove, Dale J. Lange, Michael H. Rivner, Stephen A. Goutman, Shafeeq S. Ladha, Elizabeth A. Mauricio, Robert H. Baloh, Zachary Simmons, Lindsay Pothier, Sylvia Baedorf Kassis, Thuong La, Meghan Hall, Armineuza Evora, David Klements, Aura Hurtado, Joao D. Pereira, Joan Koh, Pablo A. Celnik, Vinay Chaudhry, Karissa Gable, Vern C. Juel, Nicolas Phielipp, Adel Marei
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis
Date: 01/2021
Authors: Sabrina Paganoni, Suzanne Hendrix, Samuel P. Dickson, Newman Knowlton, Eric A. Macklin, James D. Berry, Michael A. Elliott, Samuel Maiser, Chafic Karam, James B. Caress, Margaret Ayo Owegi, Adam Quick, James Wymer, Stephen A. Goutman, Daragh Heitzman, Terry D. Heiman-Patterson, Carlayne E. Jackson, Colin Quinn, Jeffrey D. Rothstein, Edward J. Kasarskis, Jonathan Katz, Liberty Jenkins, Shafeeq Ladha, Shafeeq S. Ladha, Timothy M. Miller, Stephen N. Scelsa, Tuan H. Vu, Christina N. Fournier, Jonathan D. Glass, Kristin M. Johnson, Andrea Swenson, Namita A. Goyal
- English